Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (SKIN), innovator of Hydrafacial systems and advanced aesthetic technologies since 1997, provides this centralized hub for investors and industry professionals. Our news collection offers immediate access to verified corporate developments, combining regulatory filings with market analysis for complete transparency.
This resource serves as your primary source for tracking earnings announcements, product innovations, and strategic partnerships that shape the medical aesthetics sector. Users benefit from chronological organization of press releases alongside third-party analyses, maintaining balanced perspectives on company milestones.
Content spans critical updates including FDA clearances, international expansion efforts, and clinical study results. Each entry is vetted for relevance to investor priorities and industry trends, with particular emphasis on the company's serum-based technology advancements.
Bookmark this page for real-time updates on SKIN's market movements and professional-grade insights into the $18B global aesthetics industry. Cross-reference our archive with SEC filings using provided document identifiers for complete due diligence capabilities.
Beauty Health Company (NASDAQ:SKIN) reported strong Q1 2022 financial results, with net sales reaching $75.4 million, a 58.6% increase from Q1 2021. Key drivers included the successful launch of the Syndeo delivery system, contributing $41.6 million in sales. Gross profit stood at $51.9 million with a gross margin of 68.9%.
Despite a net income of $32.5 million, the company incurred an adjusted net loss of $8.5 million. Management raised fiscal 2022 guidance for net sales to $330 million–$340 million.
The Beauty Health Company (NASDAQ: SKIN) appointed Amy Juaristi as Head of Corporate Affairs, a new position aimed at enhancing strategic communications. With over two decades in beauty and healthcare, Juaristi previously led corporate affairs at Coty and has experience with brands like Zocdoc and Chobani. CEO Andrew Stanleick expressed enthusiasm about her leadership, highlighting her ability to effectively tell the stories of growth-driven brands. The company aims to strengthen its position in the beauty health category as it expands its global reach.
The Beauty Health Company (NASDAQ:SKIN) will report its first quarter 2022 financial results after market close on May 10, 2022. A conference call will follow at 4:30 p.m. Eastern Time to discuss these results. The company emphasizes its innovative approach in the beauty and aesthetics market with its flagship brand, HydraFacial, used in over 20,000 installations across 90 countries. This non-invasive treatment has democratized skincare, providing millions of consumer experiences annually.
The Beauty Health Company (NASDAQ:SKIN) will hold its 2022 Annual Stockholders’ Meeting on June 28, 2022, at 2:00 p.m. Eastern Time, in a virtual-only format. Stockholders can attend via live audio webcast, with no physical location available. Voting options include electronic, mail, or phone prior to the meeting. The record date for eligible stockholders is April 29, 2022. The proxy statement will be filed in mid-May, detailing how to access the meeting and vote.
The Beauty Health Company (NASDAQ:SKIN) has launched HydraFacial Syndeo, a new digitally connected device aimed at enhancing consumer and provider experiences. Available in the US, this upgrade integrates technology and data to offer personalized beauty health services. Syndeo simplifies data collection, enabling providers to understand consumer preferences better. The device retains the signature HydraFacial 3-step experience while allowing for integration with other therapeutic devices. This innovation is expected to strengthen customer relationships and increase consumer activation.
The Beauty Health Company (NASDAQ: SKIN) announced that CEO Andrew Stanleick and CFO Liyuan Woo will present at two upcoming investor conferences. The 43rd Annual Institutional Investors Conference hosted by Raymond James is scheduled for
BeautyHealth (NASDAQ: SKIN) reported Q4 2021 net sales of $77.9 million, a 105.6% increase from Q4 2020. For FY 2022, the company expects net sales between $320 million to $330 million and adjusted EBITDA around $50 million. Despite a net loss of $17.3 million in Q4 2021, adjusted EBITDA rose to $8.5 million, up from $3.6 million in Q4 2020. Cash and equivalents surged to $901.9 million, largely from a $638.7 million convertible senior notes offering. The company aims to leverage its investments and achieve historical profitability margins by 2023.
The Beauty Health Company (NASDAQ:SKIN) will release its fourth quarter and full-year fiscal 2021 financial results on February 22, 2022, after market close. A conference call to discuss the results will be held at 4:30 p.m. Eastern Time on the same day. Investors can join by calling (877) 407-9208 or accessing a live audio webcast at their investor relations page.
BeautyHealth focuses on innovative beauty health products, with its flagship HydraFacial brand available in over 87 countries and performing millions of treatments annually.
The BeautyHealth Company has opened its 9th global HydraFacial HFX Experience Center in New York City. Launched in 2018, the HydraFacial HFX program enhances aesthetic professionals' skills with a focus on client engagement, protocols, and marketing techniques. Key benefits include increased client retention, upselling confidence, and business growth strategies. With over 19,000 Delivery Systems in 87 countries, HydraFacial aims to democratize skincare with its innovative treatments. This move reinforces the company's commitment to education in the beauty health sector.
The Beauty Health Company (NASDAQ:SKIN) announced the appointment of Andrew Stanleick as President and CEO, effective February 7, 2022. With over 25 years of experience in the beauty and retail sectors, Stanleick aims to enhance the company’s growth trajectory, particularly in Asia. Previously, he held senior roles at Coty and Coach, and his track record includes overseeing high-profile brands. The executive transition comes as the company seeks to leverage digital marketing and expand its global footprint, particularly with its flagship product, HydraFacial.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
